Biggest News Aggregation in the World
📰 Solid Tumor Research News

Solid Tumor Research News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Solid Tumor Research. Real-time updates on events, politics, business and more.

Merck: Long-Term Follow-Up Data Reinforce Continued Overall Survival Benefit of BAVENCIO (avelumab) First-Line Maintenance Treatment in Patients with Advanced Urothelial Carcinoma

38-month median follow-up data from the Phase III JAVELIN Bladder 100 trial demonstrated prolonged median OS of 23.8 months with BAVENCIO plus best supportive care (BSC) in the first-line maintenance
United States United Kingdom City Of Noelle Piscitelli Thomas Powles American Society Of Clinical Oncology

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science